Actuate Therapeutics Inc
Actuate Therapeutics Inc (ACTU) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ACTU · as of Jun 9, 2026
Activity summary
Buy transactions
6
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
6.00
Buy/Sell (by trades)
Overall sentiment
Actuate Therapeutics Inc insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ACTU insider buying and selling by quarter
ACTU insider selling · ACTU insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ACTU ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ACTU executive sell shares · ACTU board member insider trading · ACTU insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 13, 2026 | SCHMITT DANIEL M President, CEO and Director | Option | 272,055 | — | Form 4 |
| Feb 13, 2026 | SCHMITT DANIEL M President, CEO and Director | Other | 121,874 | $528K | Form 4 |
| Jan 5, 2026 | THOMSON TODD S Director | Sale | 280,000 | $1.62M⚡ | Form 4 |
| Jun 27, 2025 | Bios Equity COF, LP Director | Purchase | 71,428 | $500K | Form 4 |
| Jun 27, 2025 | Kreis Leslie W. Director | Purchase | 71,428 | $500K | Form 4 |
| Jun 27, 2025 | Fletcher Aaron G.L. Director | Purchase | 71,428 | $500K | Form 4 |
| May 21, 2014 | PATTERSON ARTHUR C Director | Award | 16,000 | — | Form 4 |
| May 22, 2013 | PATTERSON ARTHUR C Director | Award | 16,000 | — | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $38K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $20K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $37K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $19K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 16,000 | $67K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 25,000 | $115K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 25,000 | $116K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 30,000 | $121K | Form 4 |
| Dec 12, 2012 | PATTERSON ARTHUR C Director | Option | 90,000 | $134K | Form 4 |
| May 24, 2012 | PATTERSON ARTHUR C Director | Option | 10,000 | $56K | Form 4 |
| May 23, 2012 | PATTERSON ARTHUR C Director | Award | 8,000 | — | Form 4 |
| Oct 12, 2011 | PATTERSON ARTHUR C Director | Option | 15,000 | $56K | Form 4 |
| May 25, 2011 | PATTERSON ARTHUR C Director | Award | 8,000 | — | Form 4 |
| May 26, 2010 | PATTERSON ARTHUR C Director | Award | 8,000 | — | Form 4 |
| Aug 27, 2009 | BEITZEL GEORGE B Director | Option | 10,000 | $19K | Form 4 |
| Aug 27, 2009 | BEITZEL GEORGE B Director | Option | 10,000 | $20K | Form 4 |
| Aug 27, 2009 | BEITZEL GEORGE B Director | Sale | 20,000 | $115K | Form 4 |
SCHMITT DANIEL M
President, CEO and Director
Date
Feb 13
Shares
272,055
Price
—
Value
—
SCHMITT DANIEL M
President, CEO and Director
Date
Feb 13
Shares
121,874
Price
$4.33
Value
$528K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ACTU insider trading
ACTU insider trades
Actuate Therapeutics Inc (ACTU) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including SCHMITT DANIEL M (President, CEO and Director), THOMSON TODD S (Director), Bios Equity COF, LP (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. ACTU insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Actuate Therapeutics Inc's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ACTU insider trading · 5 questionsThe insiders of Actuate Therapeutics Inc (ACTU) include executives and directors such as SCHMITT DANIEL M (President, CEO and Director), THOMSON TODD S (Director), Bios Equity COF, LP (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026